Eindhoven based company developing a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.
Radboud UMC (Nijmegen) spin-off CardiacBooster develops a minimally invasive cardiac assist device indicated to temporarily support the heart through episodes of acute distress such as cariogenic shock or acute heart failure.
Nijmegen based Radboudumc spin-off Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.
MILabs is a company based in Utrecht, that develops and sells state of the art molecular imaging devices, for preclinical use. In addition, MILabs is developing a clinical SPECT scanner that will have unprecedented imaging capabilities, allowing doctors to make images well beyond what they can image today.
Indigo Diabetes is a Belgian startup developing novel glucose sensor technology based on photonics, thus avoiding the need for frequent calibration
Wageningen based company active in the field of medical nutrition and functional foods. Currently develops a food ingredient with immune system enhancing properties to help combat infections.
Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.
Mellon Medical B.V. is a Dutch specialist medical technology company that develops and commercializes innovative surgical instruments to allow for single-handed stitching.
Cristal Therapeutics (formerly known as Cristal Delivery) is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies, registered as CriPec®. Cristal Delivery’s mission is optimise the therapeutic performance of drugs and thereby improve patient care.
TheraSolve develops a skin patch technology (embedded electronics) to improve drug treatment compliance.
Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.
Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.
Hemics is a medical technology company (Philips spin-out), developing an imaging apparatus to measure and monitor rheumatoid arthritis disease activity in the joints of the hands.